Table 2 Frequency of bacteraemia relapse by definitive treatment category
Definitive treatment category | Relapse (cases) | Non-relapse (controls) | Total |
|---|---|---|---|
Carbapenem | 8 (25.8%) | 37 (28.9%) | 45 (28.3%) |
Quinolones | 4 (12.9%) | 35 (27.3%) | 39 (24.5%) |
Othera | 6 (19.4%) | 21 (16.4%) | 27 (17.0%) |
Piperacillin-tazobactam/ticarcillin-clavulanate | 6 (19.4%) | 15 (11.7%) | 21 (13.2%) |
Aminoglycosides | 3 (9.7%) | 8 (6.2%) | 11 (6.9%) |
No antibiotic treatment | 2 (6.5%) | 2 (1.6%) | 4 (2.5%) |
Trimethoprim/sulphamethoxazole | 1 (3.2%) | 3 (2.3%) | 4 (2.5%) |
Cefepime | 1 (3.2%) | 2 (1.6%) | 3 (1.9%) |
Ampicillin/amoxicillin | 0 (0.0%) | 2 (1.6%) | 2 (1.3%) |
Cephazolin | 0 (0.0%) | 1 (0.8%) | 1 (0.6%) |
Ceftriaxone/ceftazidime | 0 (0.0%) | 1 (0.8%) | 1 (0.6%) |
Trimethoprim | 0 (0.0%) | 1 (0.8%) | 1 (0.6%) |
Total | 31 | 128 | 159 |